AR127856A1 - PROCESS FOR THE PREPARATION OF TEMOZOLOMIDE - Google Patents

PROCESS FOR THE PREPARATION OF TEMOZOLOMIDE

Info

Publication number
AR127856A1
AR127856A1 ARP220103318A ARP220103318A AR127856A1 AR 127856 A1 AR127856 A1 AR 127856A1 AR P220103318 A ARP220103318 A AR P220103318A AR P220103318 A ARP220103318 A AR P220103318A AR 127856 A1 AR127856 A1 AR 127856A1
Authority
AR
Argentina
Prior art keywords
temozolomide
preparation
nmci
relates
present
Prior art date
Application number
ARP220103318A
Other languages
Spanish (es)
Inventor
Castro Pacheco Ogari De
Sio Vincenzo De
Murilo Massoni
Marcelo Secatto
Original Assignee
Cristalia Produtos Quim Farmaceuticos Ltda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from BR102021024662-6A external-priority patent/BR102021024662A2/en
Application filed by Cristalia Produtos Quim Farmaceuticos Ltda filed Critical Cristalia Produtos Quim Farmaceuticos Ltda
Publication of AR127856A1 publication Critical patent/AR127856A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La presente invención se refiere a un proceso para la preparación de temozolomida a gran escala industrial que usa N-metil carbamoilimidazol (NMCI) Forma I en la preparación del intermedio clave 5-amino-N1-imidazol-1,4-dicarboxamida (carbamoil-AICA). Además, la presente invención se refiere a un proceso para preparar NMCI Forma I. La NMCI Forma I y la temozolomida se purifican por cristalización, sin emplear cromatografía en columna o extracción continua.The present invention relates to a process for the preparation of temozolomide on a large industrial scale using N-methyl carbamoylimidazole (NMCI) Form I in the preparation of the key intermediate 5-amino-N1-imidazole-1,4-dicarboxamide (carbamoyl- AICA). Furthermore, the present invention relates to a process for preparing NMCI Form I. NMCI Form I and temozolomide are purified by crystallization, without employing column chromatography or continuous extraction.

ARP220103318A 2021-12-06 2022-12-02 PROCESS FOR THE PREPARATION OF TEMOZOLOMIDE AR127856A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BR102021024662-6A BR102021024662A2 (en) 2021-12-06 PROCESS FOR THE PREPARATION OF TEMOZOLOMIDE

Publications (1)

Publication Number Publication Date
AR127856A1 true AR127856A1 (en) 2024-03-06

Family

ID=86729337

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP220103318A AR127856A1 (en) 2021-12-06 2022-12-02 PROCESS FOR THE PREPARATION OF TEMOZOLOMIDE

Country Status (3)

Country Link
CN (1) CN118355018A (en)
AR (1) AR127856A1 (en)
WO (1) WO2023102627A1 (en)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8258294B2 (en) * 2006-09-29 2012-09-04 Cipla Limited Process for the preparation of temozolomide and analogs
EP2151442A3 (en) * 2008-08-07 2011-04-06 Chemi SPA Process for preparing temozolomide
WO2010140168A1 (en) * 2009-06-03 2010-12-09 Ind-Swift Laboratories Limited Improved process for preparing temozolomide
WO2015057585A1 (en) * 2013-10-14 2015-04-23 Regents Of The University Of Minnesota Therapeutic compounds
WO2018112589A1 (en) * 2016-12-20 2018-06-28 Cristália Produtos Químicos Farmacêuticos Ltda Process for preparing temozolomide and an intermediary
WO2018122724A1 (en) * 2016-12-27 2018-07-05 Granules India Limited Temozolomide process
WO2020194168A1 (en) * 2019-03-25 2020-10-01 Shivalik Rasayan Limited Process for preparing highly pure temozolomide

Also Published As

Publication number Publication date
WO2023102627A1 (en) 2023-06-15
CN118355018A (en) 2024-07-16

Similar Documents

Publication Publication Date Title
MX2018006606A (en) Method of producing high purity d-psicose.
MX2020004844A (en) Process for purification of a neutral human milk oligosaccharide using simulated moving bed chromatography.
BR112018075433A2 (en) piperidinyl derivatives, processes for their preparation and pharmaceutical compositions containing them
MY191504A (en) Urea production process and plant
BR112017020153A8 (en) MICROSTRUCTURED CARBONATABLE CALCIUM SILICATE SLAG AND METHODS THEREOF
BRPI0519624B8 (en) process for preparing purified ansamitocins
BR112012019032A2 (en) "process for ethanol purification"
DE502006001608D1 (en) Process and installation for concentrating waste sulfuric acids from nitriding processes
AR104505A1 (en) SOLID FORMS
CL2018001720A1 (en) Crystalline polymorphic forms of obetolic acid
MX171141B (en) PROCEDURE TO PURIFY THE EFFLUENT WATER OF THE FACILITIES TO MANUFACTURE UREA
JP2013538677A5 (en)
ECSP18054047A (en) MULTI-SPECIFIC ANTIBODY MOLECULES HAVING SPECIFICITY FOR TNF-ALPHA, IL-17A, and IL-17F
CO2017010720A2 (en) Process to isolate and purify ambrox
AR127856A1 (en) PROCESS FOR THE PREPARATION OF TEMOZOLOMIDE
BR112017000090A2 (en) Method for removing dinitrotoluene impurities
AR087806A1 (en) PROCESS TO PURIFY A JET THAT INCLUDES 1,4-BUTANODIOL
BRPI0515695A (en) process for isolation of crystalline tacrolimus
BR112019007441A2 (en) method for purification of 4-hydroxyacetophenone
WO2018153381A9 (en) High-purity isothiocyanate compound preparation method for industrial production
CU20120163A7 (en) AGOMELATIN INTERMEDIATES AND METHOD OF PREPARATION OF THESE
AR098610A1 (en) PROCESS FOR THE PRODUCTION OF DIALQUIL SUCCINATE
BR112018015689A2 (en) method of producing high purity monochloric acid
ITMI20051085A1 (en) METHOD OF PURIFICATION OF CEFOTETAN
BR112017017640A2 (en) esterification process of a diol using a reactive distillation